This chapter reviews clinical and epidemiological data that support a role for ovarian steroid hormones in the migraine syndrome. Changes in the clinical presentation of migraine are discussed on the basis of current knowledge of biochemistry and pharmacology of ovarian steroids. Finally, special treatment considerations of ovarian hormone-sensitive migraine are discussed.
Get full access to this article
View all access options for this article.
References
1.
StewartWF, LiptonRB, CelentanoDD, ReedML.Prevalence of migraine headache in the United States. JAMA1992; 267: 64–9
2.
RasmussenBK, OlesenJ.Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia1992; 12: 221–8
3.
LinetMS, StewartWF, CelentanoDD, ZieglerD, SprecherN.An epidemiologic study of headache among adolescents and young adults. JAMA1989; 261: 2211–6
4.
BilleB.Migraine in school children. Acta Pediatr1962; 51: 1–151
5.
DeubnerDC.An epidemiologic study of migraine and headache in 10-20 year olds. Headache1977; 17: 173–80
6.
SillanpaaM.Prevalence of migraine and other headache in Finnish children starting school. Headache1976; 15: 288–90
7.
SparksJP.The incidence of migraine in school children: a survey by the medical officers of school association. Practitioner1978; 221: 407–11
8.
BrewisM, PoskanzerDC, RollandC, MillerH.Neurological disease in an English city. Acta Neurol Scand1966; 42: 1–89
9.
Dalsgaard-NielsenT, UlrichJ.Prevalence and heredity of migraine and migrainoid headaches among 461 Danish doctors. Headache1972; 12: 168–72
10.
EkbomJ, AhlborgB, ScheieR.Prevalence of migraine and cluster headache in Swedish men of 18. Headache1978; 18: 9–19
11.
EpsteinMT, HockadayJM, HockadayTDR. Migraine and reproductive hormones throughout the menstrual cycle. Lancet1975; 1: 543–7
12.
SinghM.Progesterone in migraine. Lancet1947; 1: 745
13.
SacksO.Migraine: The evaluation of a common disorder.Berkeley and Los Angeles: University Press1970: 169–70
14.
KeenanPA, LindamerLA.Non-migraine headache across the menstrual cycle in women with and without premenstrual syndrome. Cephalalgia1992; 12: 356–9
15.
MacGregorEA.Menstruation, sex hormones and migraine. In: MathewNT, editor. Neurologic clinics: advances in headache.Philadelphia: WB Saunders, 1997; 15: 125–41
16.
KudrowL.The relationship of headache frequency to hormone use in migraine. Headache1975; 15: 37–40
17.
SomervilleB.A study of migraine pregnancy. Neurology1972; 22: 824
18.
CallaghanN.The migraine syndrome in pregnancy. Neurology1968; 18: 197–201
19.
BousserMG, RatinahirnaH, DarboixX.Migraine and pregnancy: a prospective study in 703 women after delivery. Neurology1990; 40 Suppl 1: 437
20.
LanceJW, AnthonyM.Some clinical aspects of migraine. Arch Neurol1966; 15: 356–61
21.
ChancellerMD, WroeSJ.Migraine occurring for the first time during pregnancy. Headache1990; 30: 224–7
22.
TietjenGE.Migraine and antiphospholipid antibodies. Cephalalgia1992; 12: 69–74
23.
WainsentG, VolGN.The outcome of pregnancy in women suffering from migraine. Postgrad Med J1978; 54: 98–102
24.
SteinGS.Headaches in the first post-partum week and their relationships to migraine. Headache1981; 21: 201–5
YalomID, LundeTD, MoosRH, HamburgDA.Post partum blues syndrome. A description and related variables. Arch Gen Psychiatry1968; 18: 16–33
28.
BreslauN, DavisGC.Migraine, physical health and psychiatric disorders: a prospective epidemiologic study of young adults. J Psychiatric Res1993; 27: 211–21
29.
MathewNT.Transformed migraine, analgesic rebound, and other chronic daily headaches. Neurol Clin1997; 15: 167–86
30.
TzourioC, IglesiasS, HubertJB, VisyJM, AlperovitR, TehindrazanarA. Migraine and risk of ischemic stroke: a case-controlled study. Br Med J1993; 307: 289–92
31.
OttmanR, HongS, LiptonRB.Validity of family history data on severe headache and migraine. Neurology1993; 43: 1954–60
32.
WelchKMA, D'AndreaG, TepleyN, BarkleyG, RamadanNM.The concept of migraine as a state of central neuronal hyper-excitability. Neurol Clin1990; 8: 817–28
33.
OphoffRA, TerwindtGM, VergouweMN, van EijkRV, OefnerPJ, HoffmanSMG. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca+2 channel gene CACNL1A4. Cell1996; 87: 543–52
34.
AuroraSK, AhmadBK, WelchKMA, BhardhwajP, RamadanNM.Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology (in press)
35.
WelchKMA. Migraine. A biobehavioral disorder. Arch Neurol1987; 44: 323–7
36.
OlesenJ, LarsenB, LauritzenM.Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol1981; 9: 344–52
37.
WelchKMA, CaoY, AuroraS, VikingstadE.Functional MRI (fMRI) of visually triggered headache: stimulation, suppression and propagation of the BOLD effect. Neurology1997; 48:A85
MoskowitzMA.The neurobiology of vascular head pain. Ann Neurol1984; 16: 157–68
40.
GoadsbyPJ, EdvinssonL, EkmanR.Release of vasoactive peptides in the extracerebral circulation of men and the cat during activation of the trigeminovascular system. Ann Neurol1988; 23: 193–6
41.
GoadsbyPJ, EdvinssonL.Sumatriptan reverses the changes in calcitonin gene-related peptide seen in the headache phase of migraine. Cephalalgia1991; 11 Suppl 11: 3
42.
MoskowitzMA, BuzziMG.Neuroeffector functions of sensory fibers; implications for headache mechanisms and drug actions. J Neurol1992; 238: Suppl 1: S18–22
43.
SaxenaPR, FerrariMD.From serotonin receptor classification to the antimigraine drug sumatriptan. Cephalalgia1992; 2: 187–96
44.
LeeWS, CutrerFM, WaeberC, MoskowitzMA.Progesterone and its ring-A-induced metabolites suppress dural plasma protein extravasation by activation of peripheral GABAA-receptors. Cephalalgia1995; 15 Suppl 14: 98
45.
WeillerC, MayA, LimmrothV, JuptnerM, KaubeH, van SchayckR. Brainstem activation in human migraine attacks. Nature Med1995; 1: 658–60
46.
SomervilleBW.The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology1972; 22: 355
47.
SomervilleBW.Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology1975; 25: 239–44
De LigniercoB, VincentM, Mauvais-JarvisP, MasJL, TouboulPJ, BousserMG.Prevention of menstrual migraine by percutaneous estradiol. Br Med J1986; 293: 1540–4
50.
MearsE, GrantECG. “Anovlar” as an oral contraceptive. Br Med J1962; 5297: 75
51.
WhittyCWM, HockadayJM, WhittyMM.The effect of oral contraceptives on migraine. Lancet1966; 1: 856–96
52.
PhillipsBM.Contraceptive drugs and migraine. Br Med J1968; 299
53.
NilssonA, JacobsenL, IngemansonCA.Side effects of an oral contraceptive with particular attention to menstrual symptoms and sexual adaptation. Acta Obstet Gynecol Scand1967; 45: 537–56
54.
WelchKMA, DarnleyD, SimkinsRT.The role of estrogen in migraine: a review and hypothesis. Cephalalgia1984; 4: 227–36
55.
YonkersKA, HalbreichU, FreemanE, BrownC, EndicottJ, FrankE. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA1997; 278: 983–8
56.
DennersteinL, MorseC, BurrowsG, OatsJ, BrownJ, SmithM.Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol1988; 2: 113–20
57.
AylwardM, HollyF, ParkerRJ.An evaluation of clinical response to piperazine oestrone sulphate (“Harmogen”) in menopausal patients. Curr Med Res Opin1974; 2: 417–23
